FlexBioTech

FlexBioTech is a biotechnology company specializing in the development and manufacturing of advanced molecular diagnostic solutions. The company's core technology centers on the Flex-16 Real-Time PCR System, an automated platform designed for rapid, point-of-care testing of infectious diseases. FlexBioTech provides a diverse portfolio of PCR-based assays, including tests for COVID-19, influenza, respiratory syncytial virus (RSV), and various sexually transmitted infections. By streamlining the diagnostic workflow from sample preparation to result interpretation, the company enables healthcare providers to make faster, data-driven clinical decisions. FlexBioTech serves a global market, focusing on improving accessibility to high-accuracy molecular testing in both clinical and decentralized settings.